Cargando…
Economic burden of hemophilia B in the US: a systematic literature review
Background: Hemophilia B (HB) is a rare disease caused by congenital Factor IX (FIX) deficiency. HB requires life-long management to prevent or manage bleeding and associated morbidity. Although HB affects only a small portion of the population, it is associated with high overall cost and imposes a...
Autores principales: | Li, Nanxin (Nick), Sawyer, Eileen K., Maruszczyk, Konrad, Slomka, Marta, Burke, Tom, Martin, Antony P., O’Hara, Jamie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764337/ http://dx.doi.org/10.1080/21556660.2019.1658306 |
Ejemplares similares
-
Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys
por: Burke, Tom, et al.
Publicado: (2021) -
Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe
por: Burke, Tom, et al.
Publicado: (2021) -
Right ventricular morphology and function following stage I palliation with a modified Blalock–Taussig shunt versus a right ventricle-to-pulmonary artery conduit
por: Wong, James, et al.
Publicado: (2017) -
Telemedicine (TM) during SARS-CoV-2 Outbreak
por: Masetti, M., et al.
Publicado: (2021) -
P1704: PROJECTED LIFETIME ECONOMIC BURDEN OF SEVERE SICKLE CELL DISEASE IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)